Position in AORT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$815,458
-$1,078,967 QoQ
Shares Held
36,291
-29.8% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 207 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AORT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $611,511,222 across 25 Medical Devices names. AORT ranks #20 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
1,622,749 | $126,947,654 | |
| 2 | SYK |
Stryker Corp
|
364,761 | $114,841,353 | |
| 3 | ABT |
Abbott Laboratories
|
1,062,858 | $96,443,734 | |
| 4 | BSX |
Boston Scientific Corp
|
1,325,522 | $56,573,278 | |
| 5 | STE |
STERIS plc
|
217,064 | $45,707,166 | |
| 6 | EW |
Edwards Lifesciences Corp
|
461,098 | $41,710,925 | |
| 7 | BRKR |
Bruker Corp
|
441,505 | $26,569,770 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
82,389 | $24,190,234 |
All Filings in AORT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $815,458 | 36,291 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,894,425 | 51,732 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,009,257 | 44,053 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,878,541 | 44,368 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,299,420 | 41,782 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $310,076 | 12,615 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $309,858 | 10,838 | Shares | Defined | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||